Announcement of the BioPharma Service Newsletter, February 2022 Edition

Eurofins Group provides a wide range of analytical and testing services globally across various fields, including food, products, environment, agro, genomics, clinical diagnostics, pharmaceuticals, and materials.
In the biopharma services sector, we publish a newsletter three times a year to keep our customers informed with the latest information.
The February 2022 issue features the following six technical updates:
1. Eurofins BPT (Toronto, Canada) expands its testing and certification services related to psychedelics to support mental health treatments.
2. Eurofins CDMO assists in solving challenges arising from colon drug delivery in biological products.
3. Organoids: The next step in precision oncology.
4. The future of drug discovery: E3scan and beyond.
5. Eurofins BPT (Italy) expands its testing services for biological products with a fully operational BSL2 facility.
6. Eurofins Central Laboratory addresses challenges in PBMC processing in global clinical trials.
Please refer to "Related Links" and view "Company Release Sources" for technical information.

Inquiry about this news
Contact Us OnlineMore Details & Registration
Details & Registration
Related Links
This is the link to the source of the corporate website's release.